Table: Taiko Pharmaceutical -2024 group results

Taiko Pharmaceutical

13/02/2025 06:37

Feb 13 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2024    Dec 31, 2023   Dec 31, 2025     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           6.29            6.12           6.30                  
               (+2.8 pct)      (+21.4 pct)    (+0.1 pct)               
  Operating      629 mln        loss 1.01       215 mln                
                                              (-65.9 pct)              
  Recurring      688 mln        loss 1.25       200 mln                
                                              (-70.9 pct)              
  Net
  Net            898 mln        loss 3.61       300 mln                
                                              (-66.6 pct)              
  EPS           17.90 yen    loss 76.25 yen    5.98 yen                
  Ann Div          NIL             NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div          NIL             NIL                                 
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T